Pharmacy News and Views on GLP-1 Labeling and Testosterone Replacement - Live Webinar on November 27, 2024 7PM ET
Learn the latest insights on GLP-1 labeling updates and testosterone replacement therapy, exploring their implications, regulatory changes, and clinical impacts for pharmacy professionals.
About this webinar
Join Pete Kreckel, RPh, for an insightful session of "Pharmacy News and Views," where he will delve into the latest updates and clinical implications of GLP-1 receptor agonists and Testosterone Replacement Therapy. This session aims to equip pharmacy professionals with the most recent information on GLP-1 labeling changes, exploring how these adjustments impact prescription practices and patient outcomes. Additionally, Pete will discuss the evolving landscape of Testosterone Replacement Therapy, addressing the latest guidelines, safety concerns, and therapeutic applications. Don't miss this opportunity to stay at the forefront of pharmaceutical care and patient management in these critical areas.
At the conclusion of this course, participants will be able to:
Recognize how the latest updates on COVID-19 may impact pharmacy practice
Describe the clinical presentation, management, and prevention of seasonal or trending diseases
Review the approved indication, common adverse effects, and drug interactions for new drugs used to treat common disease states
Identify important drug alerts by the FDA and implications for patient care
